LAVAL, Quebec, June 12, 2018 /PRNewswire/ -- Bausch + Lomb,
a leading global eye health company and wholly owned
subsidiary of Valeant Pharmaceuticals International (NYSE/TSX:
VRX), today announced the introduction of Ocuvite® Blue
Light eye vitamins, a nutritional supplement formulated with lutein
and zeaxanthin, the two carotenoid pigments naturally found in the
eye. This formulation of eye nutrients includes high levels of
lutein and helps protect eyes from the blue light that reaches the
macula, which is responsible for our central vision.
"With the increasing number of hours Americans are spending on
digital devices, there is a growing need for a product that helps
our eyes filter the blue light that is emitted from these devices,"
said Joseph Gordon, president,
Consumer Healthcare and Vision Care, Bausch + Lomb.
"Ocuvite® Blue Light is specifically formulated to meet
this need and help consumers maintain their eye health in our
screen-centric world."
Most adults spend seven or more hours daily in front of digital
devices, exposing themselves to blue light for an extended period
of time. What many don't realize is that reducing their exposure to
blue light can support their eye health. Ocuvite® Blue
Light eye vitamins contain 25 milligrams of lutein and five
milligrams of zeaxanthin isomers, the key eye nutrients that help
absorb blue light before it reaches the macula.
"It is imperative to support the macular pigment layer, as it is
a significant component of eye function that helps filter blue
light," said Jeffry D. Gerson, O.D.,
FAAO, Grin Eye Care, Olathe,
Kansas. "Since Ocuvite® Blue Light contains key
ingredients naturally found in the macular pigment, I can now offer
this new supplement to my patients to help them protect their eyes
from blue light as part of their daily, digital lifestyles."
Ocuvite® Blue Light eye vitamins will be available
for purchase in the vitamin and eye care aisles at major retailers
in the third quarter of 2018 and have a suggested retail price of
$16.99.
For more information, visit www.ocuvite.com.
About Bausch + Lomb
Bausch + Lomb, a Valeant
Pharmaceuticals International, Inc. company, is a leading global
eye health organization that is solely focused on protecting,
enhancing and restoring people's eyesight. Our core businesses
include over-the-counter supplements, eye care products, ophthalmic
pharmaceuticals, contact lenses, lens care products, ophthalmic
surgical devices and instruments. Bausch + Lomb develops,
manufactures and markets one of the most comprehensive product
portfolios in the industry, which is available in more than 100
countries.
About Valeant
Valeant Pharmaceuticals International,
Inc. (NYSE/TSX: VRX) is a global company whose mission is to
improve people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.valeant.com.
Forward-looking Statements
This news release may
contain forward-looking statements which may generally be
identified by the use of the words "anticipates," "expects,"
"intends," "plans," "should," "could," "would," "may," "will,"
"believes," "estimates," "potential," "target," or "continue" and
variations or similar expressions. These statements are based upon
the current expectations and beliefs of management and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, but are not
limited to, risks and uncertainties discussed in Valeant's most
recent annual or quarterly report and detailed from time to time in
Valeant's other filings with the Securities and Exchange Commission
and the Canadian Securities Administrators, which factors are
incorporated herein by reference. Readers are cautioned not to
place undue reliance on any of these forward-looking statements.
These forward-looking statements speak only as of the date hereof.
Valeant undertakes no obligation to update any of these
forward-looking statements to reflect events or circumstances after
the date of this news release or to reflect actual outcomes, unless
required by law.
References
- Multi-Sponsor Surveys, Inc., The 2017 U.S. Study of Eye Health
in the Digital Age
Ocuvite is a trademark of Bausch & Lomb Incorporated or
its affiliates.
© 2018 Bausch & Lomb
Incorporated.
OCV.0035.USA.18
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@valeant.com
|
lainie.keller@valeant.com
|
(514)
856-3855
|
(908)
927-0617
|
(877) 281-6642 (toll
free)
|
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/bausch--lomb-introduces-ocuvite-blue-light-eye-vitamins-300664666.html
SOURCE Bausch + Lomb